Commure’s $70 Million Funding Raises Valuation to $7 Billion as It Scales Agentic AI in Healthcare

Commure raised $70 million led by General Catalyst, pushing its valuation to roughly $7 billion as it expands its agentic AI platform across hundreds of healthcare organizations.

Commure builds an AI‑powered operations platform that automates administrative and clinical workflows in hospitals, physician practices, and large health systems. Its technology uses agentic AI—software that can make decisions and execute tasks such as billing, claims processing, and patient scheduling with little human oversight.

The platform is already deployed at hundreds of healthcare organizations and thousands of care sites, handling large volumes of claims and patient interactions.

The funding round, announced by General Catalyst, values Commure at about $7 billion post‑money. The $70 million investment also includes participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis.

Commure says it will use the new capital to strengthen its AI infrastructure, broaden platform capabilities, and scale adoption in global healthcare markets. The company plans to enhance its agentic AI tools to handle more complex workflows, such as prior authorization and supply‑chain management.

The global healthcare AI market is projected to exceed $150 billion by 2030, driven by demand for tools that cut administrative waste. Many health systems are piloting agentic AI to automate prior authorization, eligibility verification, and denial management. Early adopters report reductions in processing time of up to 30 percent in some workflows.

What this means for the sector is that continued capital inflows are validating the business case for AI‑driven automation in healthcare operations.

Observers should watch whether Commure’s expanded platform leads to measurable improvements in revenue cycle metrics and whether competitors respond with similar funding rounds or product upgrades.